Research Article
Aqueous Humor Mediator and Cytokine Aberrations in Diabetic Retinopathy and Diabetic Macular Edema: A Systematic Review and Meta-Analysis
Table 1
The characteristics of included studies about DR and control groups.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
N.A: not applicable; ETDRS: Early Treatment Diabetic Retinopathy Study; DRDSS: International Clinical Diabetic Retinopathy Disease Severity Scale; ELISA: enzyme-linked immunosorbent assay; HGF: human growth factor; VEGF: vascular endothelial growth factor; IL: interleukin; MCP: monocyte chemotactic protein; CML: carboxymethyl-lysine; G-CSF: granulocyte colony-stimulating factor; GMCSF: granulocyte macrophage colony-stimulating factor; IFN: interferon; MIP: macrophage inflammatory protein; MIG: monokine induced by IFN-γ; IP: interferon gamma-induced protein; M-CSF: macrophage colony-stimulating factor; RANTES: regulated and normal T cell expressed and secreted; sTNF-R: soluble tumor necrosis factor receptor; FGF: fibroblast growth factor; ANG: angiopoietins; TGF: transforming growth factor; EGF: epidermal growth factor; PDGF: platelet-derived growth factor; ET: erythropoietin, endothelin; M/F: male/female. |